Sequential Administration of XPO1 and ATR Inhibitors Enhances Therapeutic Response in TP53-mutated Colorectal Cancer
XPO1 和 ATR 抑制剂的序贯给药可增强 TP53 突变型结直肠癌的治疗反应
期刊:Gastroenterology
影响因子:25.1
doi:10.1053/j.gastro.2021.03.022
Inoue, Akira; Robinson, Frederick S; Minelli, Rosalba; Tomihara, Hideo; Rizi, Bahar Salimian; Rose, Johnathon L; Kodama, Takahiro; Srinivasan, Sanjana; Harris, Angela L; Zuniga, Andy M; Mullinax, Robert A; Ma, Xiaoyan; Seth, Sahil; Daniele, Joseph R; Peoples, Michael D; Loponte, Sara; Akdemir, Kadir C; Khor, Tin Oo; Feng, Ningping; Roszik, Jason; Sobieski, Mary M; Brunell, David; Stephan, Clifford; Giuliani, Virginia; Deem, Angela K; Shingu, Takashi; Deribe, Yonathan Lissanu; Menter, David G; Heffernan, Timothy P; Viale, Andrea; Bristow, Christopher A; Kopetz, Scott; Draetta, Giulio F; Genovese, Giannicola; Carugo, Alessandro